Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles D. Ebert currently holds 7,611 shares of WATSON PHARMACEUTICALS INC (WPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles D. Ebert has been a net seller of WPI stock. They have purchased $0 and sold $5.8M worth of shares.
Charles D. Ebert's most recent insider trade was on Nov 6, 2013, when they sold 10,877 shares at $158.75 per share.
Charles D. Ebert serves as Executive at WATSON PHARMACEUTICALS INC (WPI). They have executed 55 insider transactions totaling $5.8M over their tenure at the company.
Charles D. Ebert holds the position of Executive at WATSON PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Charles D. Ebert has shown a selling trading pattern, with $0 in total purchases and $5.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Charles D. Ebert was on Sep 30, 2013, when they sold $2.0M worth of ACT shares. This transaction involved 13,694 shares at $144.00 per share.
Charles D. Ebert currently owns 7,611 shares of WATSON PHARMACEUTICALS INC (WPI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles D. Ebert's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles D. Ebert has 55 Form 4 filings on record as an insider at WATSON PHARMACEUTICALS INC.
Set alerts for Charles D. Ebert and 40,000+ other insiders.